Trial Profile
Assessment of the Effect of Oral Montelukast as Additional Treatment in the Management of Patients With Acute Severe Asthma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Acute asthma
- Focus Therapeutic Use
- Acronyms AcMk
- 03 Mar 2011 New trial record